The Altimmune Inc. vaccine candidate that was tested preclinically at
Read moreCOVID-19 vaccine candidate, tested at UAB, will start Phase 1 clinical trial
Home »
Pfizer Doses First Participant in Phase 3 Study Evaluating anti-TFPI Investigational Therapy, Marstacimab, for People With Severe Hemophilia A and B With or Without Inhibitors
NEW YORK–(BUSINESS WIRE) November 23, 2020 — Pfizer Inc. (NYSE:
Read moreBristol Myers Squibb Announces Deucravacitinib (BMS-986165) Demonstrated Superiority to Placebo and Otezla® (apremilast) in Pivotal Phase 3 Psoriasis Study
PRINCETON, N.J.–(BUSINESS WIRE) November 3, 2020 — Bristol Myers Squibb
Read moreMerck Presents Three-Year Survival Data for Keytruda (pembrolizumab) in Combination With Chemotherapy and Updated Phase 1/2 Data for Investigational Quavonlimab (MK-1308) in Combination With Keytruda in Advanced Non‑Small Cell Lung Cancer
KENILWORTH, N.J.–(BUSINESS WIRE) October 16, 2020 — Merck (NYSE: MRK),
Read moreVaxart Announces Dosing First Subject in Phase 1 Clinical Trial of Its Oral Tablet COVID-19 Vaccine
SOUTH SAN FRANCISCO, Calif., Oct. 13, 2020 (GLOBE NEWSWIRE) — Vaxart, Inc., (NASDAQ:
Read morePfizer and Sangamo Dose First Participant in Phase 3 Study Evaluating Hemophilia A Gene Therapy Treatment SB-525
NEW YORK & BRISBANE, Calif.–(BUSINESS WIRE) October 07, 2020 —
Read moreModerna’s coronavirus vaccine has moved to second phase of testing
The Food and Drug administration (FDA) has given approval to
Read moreFirst targeted therapy for cholangiocarcinoma shows clinical benefit in phase III trial
New data have shown for the first time that targeted
Read moreAlbireo Announces FDA Clearance of IND to Commence Phase 2 Trial of Elobixibat for the Treatment of NAFLD/NASH
BOSTON, April 11, 2019 (GLOBE NEWSWIRE) — Albireo Pharma, Inc.
Read moreProof-of-concept HIV immunotherapy study passes Phase 1 safety trial
Preliminary results from a phase I clinical trial have demonstrated
Read more